Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

DERep Home Page

["Allergy, Intolerance": "Thrombolytic medications"]

Performance/Reporting Period
2023
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to represent concepts for thrombolytic medications used for treatment of ST-segment elevation myocardial infaction (STEMI).
Data Element Scope: This value set may use a model element related to Medication.
Inclusion Criteria: Includes RXNORM codes that represent ingredients in thrombolytic medications for STEMI treatment.
Exclusion Criteria: No exclusions

Constrained to codes in the Allergy, Intolerance: Thrombolytic medications value set (2.16.840.1.113762.1.4.1170.4)

QDM Datatype and Definition

"Allergy Intolerance"

Data elements that meet criteria using this datatype should document the allergy or intolerance and its corresponding value set.

Timing:

  • The prevalencePeriod references the time from the onset date to the abatement date. Often an abatement date is not present as allergy or intolerance is ongoing.
  • The author dateTime references the recorded time.
eCQMs using this data element:
CMS996v3 - Appropriate Treatment for ST-Segment Elevation Myocardial Infarction (STEMI) Patients in the Emergency Department (ED)
QDM Attributes

prevalencePeriod

prevalencePeriod is the time from onset dateTime to abatement dateTime.

type

The characterization of the reaction (e.g., hypersensitivity, rash, gastroenteric symptoms, etc.).
Last Updated: Jul 15, 2022

We want your feedback

Feedback pertains to:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.